Clinical Trial Update: Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating cost-effectiveness of genotype-guided antiplatelet therapy in STEMI patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Snippet

Sponsor: Vera HM Deneer | Conditions: Myocardial Infarction, STEMI | Phase 4 | Status: COMPLETED